CTRI/2020/12/029985招募中2 期
An Open-labeled study to investigate efficacy of add-on personalized Ayurveda intervention in Covid-19 Patients with moderate diseases severity with type 2 diabetes followed by 60 day follow-up of post-viral syndrome post Covid-19 in comparison to standalone treatment based on ICMR guidelines - AAIC
AVP Research Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •(i) Confirmed case of COVID with RT-PCR method not requiring ventilator or Intensive Care Unit support at the time of induction (ii) Aged above 18 years and less than equal to 70 years willing to give informed consent. (iii) Patients with Diabetes Mellitus Type II as co-morbidity (v) Arterial SpO2 in Room air less than or equal to 95 % or more than or equal to 90% at baseline (vi) NLR more than or equal to 3 (vii) IL6 not less than 25 (viii) CT score not less than 25% and not more than 50% of Lung consolidation (CORAD Score equivalent to the same) (ix) Patients on both Remdisivir and steroids
排除标准
- •Co-morbidities like acute and advanced stage of chronic obstructive pulmonary disease, malignancy, chronic liver diseases, recent history of cardiovascular events, renal diseases, HIV patients, Pregnant and Lactating women, acute inflammatory complications of diabetes like non-healing ulcers /severe neuropathy, Patient requiring ventilator support as decided by medical team, Type I Diabetes Mellitus, History of CVA or Stroke. Covid-19 induced hyperglycemia, any subject having any affiliation to the participating institutions will be excluded.
研究者
相似试验
已完成
不适用
Pain Reduction in Osteoarthritis of the knee using oral MethotrexateOsteoarthritis of the kneeMusculoskeletal DiseasesOsteoarthritisISRCTN66676866niversity of Leeds (UK)30
进行中（未招募）
不适用
An open label study to assess the effectiveness of oral methotrexate in reducing pain in knee osteoarthritis - Pain Reduction in Osteoarthritis using oral MethotrexateEUCTR2008-008237-11-GBniversity of Leeds
进行中（未招募）
1 期
A Phase 2 study of AF37702 Injection for anemia in patients with pure red cell aplasia.EUCTR2005-004944-30-GBTakeda Development Centre Europe Ltd22
进行中（未招募）
1 期
A Phase 2 study of AF37702 Injection for anemia in patients with pure red cell aplasia.Anemia caused by Antibody-Mediated Pure Red Cell Aplasia in Patients with Chronic Kidney DiseaseMedDRA version: 18.0Level: PTClassification code 10002965Term: Aplasia pure red cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2005-004944-30-DETakeda Development Centre Europe Ltd40
已完成
不适用
An open-label study evaluating the effectiveness of aripiprazole for schizophrenia patients with dopamine supersensitivity psychosis.Schizophrenia, Schizaffective disorderJPRN-UMIN000012574Department of Psychiatry, Chiba University Graduate School of Medicine20